(Q63062510)
Statements
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Ozarelix, in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (English)
0 references
September 2008
0 references
August 2011
0 references
860
0 references
50 year
0 references